Related Experiment Videos
[Adhesion molecules and cancer metastasis]
1Dept. of Surgery II, Osaka University Medical School, Japan.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|November 1, 1991
Summary
Reduced expression of the cell-cell adhesion molecule E-cadherin (E-CD) correlates with increased metastasis in esophageal, gastric, and breast cancers. Lower E-CD levels indicate a higher risk of tumor cell detachment and spread.
Area of Science:
- Molecular Biology
- Oncology
- Cell Biology
Context:
- Advances in molecular biology and genetic technologies facilitate the study of cell adhesion molecules.
- Cell-cell and cell-extracellular matrix interactions are crucial in cancer metastasis.
- Active peptides targeting adhesion receptors have been explored to inhibit tumor metastasis.
Purpose:
- To investigate the correlation between E-cadherin (E-CD) expression and metastasis in human esophageal, gastric, and breast cancers.
- To utilize immunohistochemical staining with an anti-human E-CD antibody (HE-CD-1) for assessing E-CD levels.
- To compare E-CD expression in cancerous tissues with normal epithelium and between metastatic and non-metastatic tumors.
Summary:
- E-cadherin (E-CD) expression was significantly reduced in over half of the analyzed human esophageal, gastric, and breast cancer cases compared to normal epithelium.
- Metastatic tumors within primary sites exhibited significantly lower E-CD expression than non-metastatic tumors.
- These findings suggest that decreased E-CD expression impairs tumor cell adhesion, potentially enabling detachment, circulation, and secondary site colonization.
Impact:
- Provides evidence linking reduced E-cadherin expression to enhanced metastatic potential in common human cancers.
- Highlights the role of cell-cell adhesion molecules as potential therapeutic targets for preventing cancer metastasis.
- Contributes to understanding the molecular mechanisms underlying cancer progression and the formation of secondary tumors.